Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Overview of attention for article published in The Lancet, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 34 news outlets
blogs: 2 blogs
policy: 2 policy sources
twitter: 610 X users
patent: 5 patents

facebook: 1 Facebook page
reddit: 4 Redditors
video: 1 YouTube creator
podcasts: 2 podcasts

Readers on

mendeley: 262 Mendeley

So far, Altmetric has seen 6 policy documents that reference this research output.

Предварительные рекомендации по применению вакцины ChAdOx1-S [‎рекомбинантной]‎ против COVID-19 (‎вакцина Astra Zeneca COVID-19 AZD1222, Vaxzevria™, SII COVISHIELD™)‎: Временное руководство (‎Первый выпуск:10 февраля 2021 г., Обновлено: 21 апреля 2021 г., Обновлено: 30 июля 2021 г., Последнее обновление: 15 марта 2022 г.)‎

Cited by World Health Organization (WHO) on 24 Jun 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Recomendaciones provisionales para el uso de la vacuna ChAdOx1-S [‎recombinante]‎ contra la COVID-19 (‎vacuna de AstraZeneca contra la COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™)‎: orientación provisional, primera publicación: 10 de febrero de 2021, actualización: 21 de abril de 2021, actualización: 30 de julio de 2021, última actualización: 15 de marzo de 2022

Cited by World Health Organization (WHO) on 04 May 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [‎recombinant]‎ contre la COVID-19 (‎vaccin anti-COVID-19 d’AstraZeneca AZD1222 Vaxzevria™, SII COVISHIELD™)‎ : orientations provisoires, première publication : 10 février 2021, mise à jour le 21 avril 2021, mise à jour le 30 juillet 2021, dernière mise à jour le 15 mars 2022

Cited by World Health Organization (WHO) on 21 Apr 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

ATAGI recommendations on the use of a booster dose of COVID-19 vaccine

Cited by Australian Department of Health on 25 Mar 2022

We develop and deliver policies and programs and advise the Australian Government on health, aged care and sport. We work with a wide range of stakeholders to ensure better health for all Australians.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity, including 2 additional policy documents.